BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21788320)

  • 1. The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction.
    Kim WM; Jeong CW; Lee SH; Kim YO; Cui JH; Yoon MH
    Anesth Analg; 2011 Oct; 113(4):934-40. PubMed ID: 21788320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain.
    Kimura M; Obata H; Saito S
    Anesth Analg; 2012 Aug; 115(2):443-9. PubMed ID: 22575568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model.
    Yin Q; Cheng W; Cheng MY; Fan SZ; Shen W
    Behav Pharmacol; 2010 Oct; 21(7):595-601. PubMed ID: 20736819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.
    Kolosov A; Aurini L; Williams ED; Cooke I; Goodchild CS
    Pain Med; 2011 Jun; 12(6):923-41. PubMed ID: 21539704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
    Obata H; Kimura M; Nakajima K; Tobe M; Nishikawa K; Saito S
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1059-65. PubMed ID: 20558774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
    Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
    Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology.
    Urch CE; Donovan-Rodriguez T; Gordon-Williams R; Bee LA; Dickenson AH
    J Pain; 2005 Dec; 6(12):837-45. PubMed ID: 16326372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
    Li FC; Sun XJ; Hu WH; Jen MF
    Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain.
    Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK
    Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
    Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antinociception of intrathecal sildenafil with clonidine in the rat formalin test.
    Yoon MH; Kim CM; Lee HG; Kim WM; An TH; Kim YO; Huang LJ
    Pharmacol Biochem Behav; 2009 Jun; 92(4):583-8. PubMed ID: 19254741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
    Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH
    Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of drug interaction between morphine and neostigmine in rats with nerve-ligation injury.
    Hwang JH; Hwang KS; Choi Y; Park PH; Han SM; Lee DM
    Anesth Analg; 2000 Feb; 90(2):421-6. PubMed ID: 10648332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain.
    Tong W; Wang W; Huang J; Ren N; Wu SX; Li YQ
    Biochem Biophys Res Commun; 2010 May; 395(4):572-6. PubMed ID: 20399746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
    Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
    Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.